Low levels of C-peptide may not be a sign of pancreatic β-cell death or apoptosis: New insight into pancreatic endocrine function and indications for metabolic surgery

Surgery for Obesity and Related Diseases

Volumn 9, Issue 6, 2013, Pages 1022-1024

  Cohen, Ricardo V ^a   Petry, Tarissa Z ^a   Paulo Caravatto, Pedro ^a  

^a Hospital Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE;

APOPTOSIS; ARTICLE; BARIATRIC SURGERY; CELL DEATH; CELL DEDIFFERENTIATION; ENDOCRINE FUNCTION; GLYCEMIC CONTROL; INSULIN RESISTANCE; METABOLIC STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL;

APOPTOSIS; BARIATRIC SURGERY; BIOLOGICAL MARKERS; C-PEPTIDE; CELL DEATH; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MALE; OBESITY, MORBID; PANCREATIC FUNCTION TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84890428420     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2013.08.004     Document Type: Article

References (40)

1. E. Ferrannini Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects Endocr Rev 19 1998 477 490
2. D.F. Steiner, D. Cunningham, L. Spigelman, and B. Aten Insulin biosynthesis: Evidence for a precursor Science 157 1967 697 700
3. J. Wahren, A. Kallas, and A.A. Sima The clinical potential of C-peptide replacement in type 1 diabetes Diabetes 61 2012 761 772
4. 2: A report of 2 cases Surg Obes Relat Dis 3 2007 195 197
5. A.L. DePaula, A.L. Macedo, and N. Rassi Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surg Endosc 22 2008 706 716
6. 2 (LBMI) Obes Surg 19 2009 307 312
7. R. Cohen, P.P. Caravatto, and J.L. Correa Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index Surg Obes Relat Dis 8 2012 375 380
8. W.-J. Lee, K. Chong, and K.H. Ser C-peptide predicts the remission of type 2 diabetes after bariatric surgery Obes Surg 22 2011 293 298
9. A. Escalona, R. Yáñez, and F. Pimentel Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity Surg Obes Relat Dis 6 2010 126 131
10. W.J. Lee, K.H. Ser, and K. Chong Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: Efficacy and change of insulin secretion Surgery 147 2010 664 669
11. S.R. Kashyap, and R.A. DeFronzo The insulin resistance syndrome: Physiological considerations Diab Vasc Dis Res 4 2007 13 19
12. C.S. Tam, W. Xie, W.D. Johnson, W.T. Cefalu, L.M. Redman, and E. Ravussin Defining insulin resistance from hyperinsulinemic-euglycemic clamps Diabetes Care 35 2012 1605 1610
13. R.A. DeFronzo, and E. Ferrannini Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194
14. K.J. Chang-Chen, R. Mullur, and E. Bernal-Mizrachi Beta-cell failure as a complication of diabetes Rev Endocr Metab Disord 9 2008 329 343
15. P. Yi, J.S. Park, and D.A. Melton Betatrophin: A hormone that controls pancreatic β cell proliferation Cell 153 2013 747 758
16. E. Kugelberg Diabetes: Betatrophin - inducing β-cell expansion to treat diabetes mellitus? Nat Rev Endocrinol 9 2013 379
17. M.K. Lingohr, R. Buettner, and C.J. Rhodes Pancreatic β-cell growth and survival-a role in obesity-linked type 2 diabetes? Trends Mol Med 8 2002 375 384
18. F. Rubino Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis Diabetes Care 31 Suppl 2 2008 S290 S296
19. B. Laferrère, J. Teixeira, and J. McGinty Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 2008 2479 2485
20. L. Sjöström, A.K. Lindroos, and M. Peltonen Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N Engl J Med 351 2004 2683 2693
21. L. Sjöström, K. Narbro, and C.D. Sjöström Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 2007 741 752
22. K. Sjoholm, Å. Anveden, and M. Peltonen Evaluation of current eligibility criteria for bariatric surgery: Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study Diabetes Care 36 2013 1335 1340
23. L. Sjöström, M. Peltonen, and P. Jacobson Bariatric surgery and long-term cardiovascular events JAMA 307 2012 56 65
24. P.R. Schauer, B. Burguera, and S. Ikramuddin Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 2003 467 484
25. R.V. Cohen, J.C. Pinheiro, C.A. Schiavon, J.E. Salles, B.L. Wajchenberg, and D.E. Cummings Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity Diabetes Care 35 2012 1420 1428
26. J.B. Dixon, P.E. O'Brien, and J. Playfair Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial JAMA 299 2008 316 323
27. P.R. Schauer, S.R. Kashyap, and K. Wolski Bariatric Surgery versus intensive medical therapy in obese patients with diabetes N Engl J Med 366 2012 1567 1576
28. G. Mingrone, S. Panunzi, and A. De Gaetano Bariatric surgery versus conventional medical therapy for type 2 diabetes N Engl J Med 366 2012 1577 1585
29. American Diabetes Association Summary of Revisions for the 2013 Clinical Practice Recommendations Diabetes Care 36 Suppl 1 2013 S3
30. C. Talchai, S. Xuan, H.V. Lin, L. Sussel, and D. Accili Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure Cell 150 2012 1223 1234
31. J.J. Holst, M. Christensen, and A. Lund Regulation of glucagon secretion by incretins Diabetes Obes Metab 13 Suppl 1 2011 89 94
32. T. Vilsbøll, and J.J. Holst Incretins, insulin secretion and type 2 diabetes mellitus Diabetologia 47 2004 357 366
33. S. Crunkhorn Betatrophin boosts β-cells Nat Rev Drug Discov 12 2013 504
34. R.V. Cohen, M.G. Neto, and J.L. Correa A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes J Clin Endocrinol Metab 98 2013 E279 E282
35. D.M. Breen, B.A. Rasmussen, A. Kokorovic, R. Wang, G.W. Cheung, and T.K. Lam Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes Nat Med 18 2012 950 955
36. S. Salinari, C. Debard, and A. Bertuzzi Jejunal Proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance PLoS One 8 2013 e56258
37. S. Puri, and M. Hebrok Diabetic β cells: To be or not to be? Cell 150 2012 1103 1104
38. Y. Dor, and B. Glaser β-cell dedifferentiation and type 2 diabetes N Engl J Med 368 2013 572 573
39. S. Porat, N. Weinberg-Corem, and S. Tornovsky-Babaey Control of pancreatic ß-cell regeneration by glucose metabolism 13 2011 440 449
40. J. Jiao, E.J. Bae, and G. Bandyopadhyay Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa Rats Diabetes 62 2013 1074 1083